术前失脂症与子宫内膜癌患者的预后之间的关联:回顾性队列研究
Song Li1,2, Rong-He Sun3, Qing Chen1
1Center of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China.
The Kaohsiung journal of medical sciences
|March 10, 2026
概括
术前高甘油三 (TG) 和低高密度脂蛋白胆固醇 (HDL-C) 水平会对子宫内膜癌 (EC) 患者的生存率产生负面影响. 这些脂质水平可以作为预测EC预后的重要生物标志物.
科学领域:
- 在瘤学瘤学.
- 代谢障碍 代谢障碍 代谢障碍
- 临床生物化学 临床生物化学
背景情况:
- 子宫内膜癌 (EC) 经常与代谢障碍有关.
- 了解影响EC预后的因素对于患者管理至关重要.
研究的目的:
- 调查手术前脂质失调症对子宫内膜癌 (EC) 患者预后的独立影响.
- 确定特定的脂质参数,可以作为EC的预后生物标志物.
主要方法:
- 对经过手术治疗的194名EC患者的回顾性分析.
- 根据中国的指导方针,将患者分为高血脂和低血脂组.
- 考克斯的比例危险回归模型用于分析整体存活时间 (OS) 的风险因素.
主要成果:
- 单变量分析确定了年龄,手术前的甘油三 (TG),高密度脂蛋白胆固醇 (HDL-C),FIGO阶段和组织类型作为OS的危险因素.
- 多变量分析证实,高TG (≥1.7 mmol/L) 和低HDL-C (<1.0 mmol/L) 显著对OS产生负面影响.
- 高TG患者的中位生存时间显著缩短,低HDL-C患者的中位生存时间更长.
结论:
- 术前TG升高和术前HDL-C水平降低与子宫内膜癌患者的预后较差有关.
- 手术前的脂质概况,特别是TG和HDL-C,可以作为评估EC预后的有价值的生物标志物.
- 进一步的研究可能会探索针对失脂症的治疗策略,以改善EC结果.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
727
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
727
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
340
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
340
